On February 4, World Cancer Day, the focus is on advances and challenges in cancer research and treatment. Two new audio reports address key issues in modern oncology. The two interviews with experts from the NCT Heidelberg shed light on different perspectives on diagnosis, therapy, and research:

Dirk Jäger, Managing Director at NCT Heidelberg and Head of the Department of Medical Oncology at Heidelberg University Hospital (UKHD), will be featured on the program “Der Tag” on HR2 on February 4 at 6 p.m. The conversation will shed light on new cancer therapies, how diagnostics and treatment have changed in recent years, and the role that research, prevention, personalized medicine, and clinical trials play in this context.
Media library for listening: https://www.hr2.de/podcasts/der-tag/index.html (Dirk Jäger from minute 20:30)
To the post: https://www.hr-inforadio.de/programm/der-tag/der-tag-diagnose-krebs--auf-der-suche-nach-neuen-therapien,epg-mi-13852.html

The research podcast “Tatort Krebs” (Cancer Scene) by the National Decade Against Cancer is launching its third season on World Cancer Day. In it, Stefan Fröhling, Executive Director at NCT Heidelberg and Head of the Department of Translational Medical Oncology at the German Cancer Research Center (DKFZ), talks about new developments in cancer research, tumor heterogeneity, and the HEROES-AYA project. The podcast presents projects and issues and gives a voice to discussion partners from science, clinics, and patient advocacy groups. Go directly to the episode with Stefan Fröhling https://tatort-krebs-bmbf.podigee.io/17-folge2-heroesaya-fr-hling-tatort-krebs.

Both contributions highlight how closely research, clinical practice, and health policy frameworks are linked and which developments c